Since the drug resistance in hormone treatment of breast cancer caused by targeting classic estrogen receptors, the discovery of GPER brought a new breakthrough point to illustrate the mechanism of the effects of estrogen or estrogenic substances on proliferation and apoptosis process. The gene discussed is ESR1; the disease is breast carcinoma.